13. immune system Flashcards
do autoimmune diseases effect females or males more
% population effected by autoimmune diseases
females
5%
categories of autoimmune diseases
what does this depend on?
organ specific
systemic
nature of autoantigens recognised
mechanisms that prevent autoimmune diseases
central tolerance
peripheral tolerance
central tolerance
- Generated in the primary lymphoid organs
- For immature lymphocytes, strong interaction with antigen induces apoptosis (death) rather than activation
- Leads to clonal deletion of immature autoreactive lymphocytes that interact with autoantigens in the primary lymphoid organs
not perfect
monogenic autoimmune disease called ‘Autoimmune Polyendocrine Syndrome type-1 (APS-1)’ in which there are mutations in the AIRE gene (autoimmune regulator).
peripheral tolerance
- Ignorance - tissue antigens that are not exposed to lymphocytes (i.e. are sequestered), or are presented in such small amounts that they cannot activate lymphocytes.
- Inhibition of autoreactive T cells by regulatory T cells (Treg)- express transcription factor Foxp3
- mutations cause IPEX gene
- Checkpoints’ control autoreactive T cell activity
- APC cells express checkpoint molecules (PDL) interact with PD-1 on t cells- switches off t cells
Susceptibility to autoimmune diseases:
- Environmental - infections may either increase the risk (trigger or exacerbate), or decrease the risk (eg. Hygiene Hypothesis)
- Genetic - some individuals have a greater risk than others (eg. sex, HLA type)
Increasing incidence in UK due to lifestyle hygiene hypothesis
Sex associations:
males have testosterone- immunosuppressive
men have less effective immune responses
HLA associations
HLA II genes occur more in those with autoimmune diseases
some genes encoding HLA can affect- different HLA bind to different peptides
HLA-DR4 alleles are associated with rheumatoid arthritis
Rheumatoid arthritis (RA)
primarily targets synovial joints
Rheumatoid factor (RF) is anti-IgG(Fc) autoantibodies:
IgM factor has worse prognosis
- Occurs in some other autoimmune diseases during chronic infection and in healthy individuals -not specific for RA
- IgM RF (particularly high titre) indicative of more aggressive disease with relatively poor prognosis
Not a specific maker for RA
Anti-citrullinated protein antigen (ACPA) antibodies
- Present in about 85% of RA patients -quite sensitive for RA
- Rare in other diseases and healthy individuals -highly specific for RA
- Citrulline is an amino acid formed by the enzymatic de-imination of arginine in proteins.
- Citrullinated proteins (eg. fibrin) occur in synovial membranes of affected joints in RA
- ACPA is prognostic of more aggressive, erosive disease in RA
- The presence of ACPA in patients with undifferentiated arthritis indicates probable progression to RA
Synovitis in RA
Lymphocytic infiltration of synovium, and cytokine production, play an important part in the damage to joints in RA. Understanding this has led to novel targeted treatments in RA using cytokine-neutralizing monoclonal antibodies and other ‘biologics’.
Identified risk factors for ACPA-positive RA
HLA-DR shared epitope
important structural features in their peptide binding clefts;
May favour presentation of autoantigenic peptide to autoreactive T cells.
PTPN22 (R620W)
Protein tyrosine phosphatase that reduces T cell signaling;
Trp620 variant has enhanced enzymatic activity, raising the threshold for T cell signaling; associated with multiple autoimmune diseases
May lead to:
- less clonal deletion of autoreactive T cells
- less Treg activity
Smoking
May induce citrullination of lung proteins
Genetic and environmental factors interact to determine an individual’s overall risk of developing RA.